Qlaris Phase 2 Study in NTG Patients

Conditions:   Normal Tension Glaucoma;   Low-Tension Glaucoma, Bilateral;   Low-Tension Glaucoma, Unspecified Eye;   Glaucoma Interventions:   Drug: QLS-111 ophthalmic solution, (0.015%);   Drug: QLS-111 ophthalmic solution, (0.03%);   Other: QLS-111 ophthalmic vehicle solution Sponsor:   Qlaris Bio, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials